Stay updated on Monoclonal Antibody BMS-986218 Clinical Trial
Sign up to get notified when there's something new on the Monoclonal Antibody BMS-986218 Clinical Trial page.
Latest updates to the Monoclonal Antibody BMS-986218 Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.3 to v3.3.4 is displayed on the page, a minor update that does not affect study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study’s Locations section was updated with new site regions and countries, expanding the list of recruitment sites (e.g., multiple US states and international regions). The revision also removed or reorganized several previously listed location groupings.SummaryDifference1%
- Check53 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check60 days agoChange DetectedRemoved the government funding lapse notice that previously warned of possible website delays. The trial details and official study information are unchanged.SummaryDifference0.2%
- Check74 days agoChange DetectedResults for the study were posted on 2025-04-24 and study record dates were updated (including primary/completion dates). The update also reflects changes to enrollment and locations on the page.SummaryDifference0.2%
- Check103 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference2%
Stay in the know with updates to Monoclonal Antibody BMS-986218 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Monoclonal Antibody BMS-986218 Clinical Trial page.